Canatu Plc's new series A shares subscribed for with option rights 2024-I have been registered with the Finnish Trade Register

Canatu Plc Company release 20 August 2026 at 10:15 a.m. EEST

Canatu Plc’s new series A shares subscribed for with option rights 2024-I have been registered with the Finnish Trade Register

During the subscription window of Canatu Plc’s (the “Company”) option rights 2024-I between 1 April 2026 and 30 June 2026, a total of 25,000 new series A shares in the Company have been subscribed for with the option rights 2024-I.

The aggregate subscription price of EUR 87,500.00 paid for the subscriptions made with the option rights 2024-I will be entered in its entirety into the Company’s reserve for invested unrestricted equity.

As a result of the share subscriptions, the number of the Company’s series A shares is in total 33,753,036, the number of series B shares is in total 1,050,000 and the number of series C shares is in total 0. The total number of the Company’s shares and votes after the share subscriptions is 34,803,036.

The new series A shares subscribed for with the option rights 2024-I have been registered with the Finnish Trade Register today, 20 August 2026. The new series A shares confer shareholder rights on their holders from the date of the registration. The new series A shares will be admitted to public trading on the Nasdaq First North Growth Market Finland marketplace maintained by Nasdaq Helsinki Oy together with the pre-existing series A shares on or about 21 August 2026.

The share subscription period for the option rights 2024-I will end on 31 December 2029.

Additional information concerning the option plan 2024-I is available on the Company’s website at: https://canatu.com/investors/share-information/warrants-and-option-plans/.

Additional information

Maximilian Slawinski, CEO, maximilian.slawinski@canatu.com

Mikko Vesterinen, CFO, mikko.vesterinen@canatu.com

Certified adviser

DNB Carnegie Investment Bank AB (publ), tel. +46 (0) 8 588 685 70

About Canatu

Canatu (CANATU, Nasdaq First North, Finland) is a deep technology scaleup company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, robotics, mobility and defence, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.

Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling more effective manufacturing of the most advanced chips. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and dry deposition method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.

Headquartered in Finland, Canatu also operates in the US, Japan and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has 185 full-time equivalent employees representing over 35 nationalities, with nearly 20% holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.